Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis

被引:107
|
作者
Misiak, Blazej [1 ]
Stanczykiewicz, Bartlomiej [2 ]
Laczmanski, Lukasz [3 ]
Frydecka, Dorota [2 ]
机构
[1] Wroclaw Med Univ, Dept Genet, 1 Marcinkowski St, PL-50368 Wroclaw, Poland
[2] Wroclaw Med Univ, Dept Psychiat, 10 Pasteur St, PL-50367 Wroclaw, Poland
[3] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, 12 Weigla St, PL-11400 Wroclaw, Poland
关键词
Schizophrenia; Lipids; Lipoproteins; Metabolic dysregulation; Cholesterol; Psychotic disorders; ULTRA-HIGH-RISK; IMPAIRED GLUCOSE-TOLERANCE; 1ST EPISODE SCHIZOPHRENIA; BODY-MASS INDEX; DRUG-NAIVE; METABOLIC SYNDROME; METHYLENETETRAHYDROFOLATE REDUCTASE; CHOLESTEROL-METABOLISM; FATTY-ACIDS; ASSOCIATION;
D O I
10.1016/j.schres.2017.03.031
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Dyslipidaemia is one of the most prevalent metabolic disturbances observed in schizophrenia patients and has been largely attributed to the effects of poor lifestyle habits and adverse effects of antipsychotic treatment. However, less is known whether patients with first-episode non-affective psychosis (FENP) present subthreshold indices of dyslipidaemia. Therefore, we tested the hypothesis whether subclinical lipid profile alterations occur already in antipsychotic-naive FENP patients. Methods: In this systematic review and meta-analysis we adhered to the PRISMA guidelines and searched PubMed, CINAHL Complete, Academic Search Complete, ERIC and Health Source: Nursing/Academic Edition from database inception to Dec 12, 2016, for case-control studies measuring the levels of total cholesterol, low-and high-density lipoproteins (LDL and HDL) and triglycerides in patientswith FENP and controls. W calculated effect size (ES) estimates as Hedges'g and pooled data using random-or fixed-effects models depending on heterogeneity. Our study was registered in the PROSPERO database (CRD42016051732). Results: Out of 2466 records identified, 19 studies representing 1803 participants were finally included in our systematic review and meta-analysis. Pooled analysis revealed that FENP patients had significantly lower levels of total cholesterol [ES = -0.16 (95% CI: -0.27, -0.06), p = 0.003], LDL [ES = -0.13 (95% CI: -0.24, -0.01), p= 0.034] and HDL [ES=-0.27 (95% CI:-0.49,-0.05), p= 0.018] as well as significantly higher levels of triglycerides [ES= 0.22 (95% CI: 0.11, 0.32), p b 0.001] compared to controls. After removing single studies in sensitivity analysis, ES estimate for LDL levels was insignificant. Conclusions: Antipsychotic-naive patients with FENP present subclinical dyslipidaemia. Future studies should disentangle whether our findings reflect disease-specific mechanisms. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:18 / 27
页数:10
相关论文
共 50 条
  • [1] Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: Authors' reply
    Misiak, Blazej
    Stanczykiewicz, Bartlomiej
    Laczmanski, Lukasz
    Frydecka, Dorota
    SCHIZOPHRENIA RESEARCH, 2018, 192 : 471 - 472
  • [2] Letter to the Editor: Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis
    Perry, B. I.
    Singh, S. P.
    SCHIZOPHRENIA RESEARCH, 2018, 192 : 461 - 462
  • [3] Metabolic syndrome in antipsychotic-naive patients with first-episode psychosis: a systematic review and meta-analysis
    Garrido-Torres, Nathalia
    Rocha-Gonzalez, Idalino
    Alameda, Luis
    Rodriguez-Gangoso, Aurora
    Vilches, Ana
    Canal-Rivero, Manuel
    Crespo-Facorro, Benedicto
    Ruiz-Veguilla, Miguel
    PSYCHOLOGICAL MEDICINE, 2021, 51 (14) : 2307 - 2320
  • [4] Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
    Fernandez-Egea, Emilio
    Bernardo, Miguel
    Donner, Thomas
    Conget, Ignacio
    Parellada, Eduard
    Justicia, Azucena
    Esmatjes, Enric
    Garcia-Rizo, Clemente
    Kirkpatrick, Brian
    BRITISH JOURNAL OF PSYCHIATRY, 2009, 194 (05) : 434 - 438
  • [5] Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis
    Riecher-Roessler, A.
    Rybakowski, J. K.
    Pflueger, M. O.
    Beyrau, R.
    Kahn, R. S.
    Malik, P.
    Fleischhacker, W. W.
    PSYCHOLOGICAL MEDICINE, 2013, 43 (12) : 2571 - 2582
  • [6] Reward disturbances in antipsychotic-naive patients with first-episode psychosis and their association to glutamate levels
    Tangmose, Karen
    Rostrup, Egill
    Bojesen, Kirsten B.
    Sigvard, Anne
    Jessen, Kasper
    Johansen, Louise Baruel
    Glenthoj, Birte Y.
    Nielsen, Mette Odegaard
    PSYCHOLOGICAL MEDICINE, 2023, 53 (04) : 1629 - 1638
  • [7] Spontaneous parkinsonism in antipsychotic-naive patients with first-episode psychosis
    Chong, SA
    Subramaniam, M
    Verma, S
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (07): : 429 - 431
  • [8] Blood cell count in antipsychotic-naive patients with non-affective psychosis
    Garcia-Rizo, Clemente
    Casanovas, Marta
    Fernandez-Egea, Emilio
    Oliveira, Cristina
    Meseguer, Ana
    Cabrera, Bibiana
    Mezquida, Gisela
    Bioque, Miquel
    Kirkpatrick, Brian
    Bernardo, Miquel
    EARLY INTERVENTION IN PSYCHIATRY, 2019, 13 (01) : 95 - 100
  • [9] Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis A Systematic Review and Meta-Analysis
    Lee, Maria
    Cernvall, Martin
    Borg, Jacqueline
    Plaven-Sigray, Pontus
    Larsson, Cornelia
    Erhardt, Sophie
    Sellgren, Carl M.
    Fatouros-Bergman, Helena
    Cervenka, Simon
    JAMA PSYCHIATRY, 2024, : 468 - 476
  • [10] GLUCOSE TOLERANCE IN NEWLY DIAGNOSED, ANTIPSYCHOTIC-NAIVE PATIENTS WITH NON-AFFECTIVE PSYCHOSIS
    Kirkpatrick, Brian W.
    Fernandez-Egea, E.
    Garcia-Rizo, C.
    Parcllada, E.
    Justicia, A.
    Bernardo, M.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 68 - 68